Skip to main content
SpringerLink
Log in

Serotypes and resistance patterns ofStreptococcus pneumoniae causing systemic disease in northern norway

  • Notes
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

Abstract

During the period 1985–1990,Streptococcus pneumoniae was isolated from 97 patients with systemic pneumococcal disease in Northern Norway. Systemic disease occurred most frequently in the age groups 0–4 years and > 60 years. An increasing incidence was observed, especially among children less than five years old. Serotypes covered by the 23-valent pneumococcal polysaccharide vaccine were found in 86 of 97 (88.7 %) isolates. The vaccine did not cover 16.7 % of the systemic isolates from children less than five years old. Reduced sensitivity to penicillin was found in one isolate (1.0 %) which was resistant to ampicillin, doxycycline and chloramphenicol. The E-test and the Rosco agar diffusion test differed in sensitivity to penicillin, chloramphenicol, ciprofloxacin and erythromycin. Three serotype 12F strains showed unusual cross-resistance to chloramphenicol and erythromycin.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bruyn GAW, van der Meer JWM, Hermans J, Knoppert W: Pneumococcal bacteremia in adults over a 10-year period at University Hospital Leiden. Reviews of Infectious Diseases 1988, 2: 446–450.

    Google Scholar 

  2. Douglas RM, Paton JC, Duncan SJ, Hansman DJ: Antibody response to pneumococcal vaccination in children younger than five years of age. Journal of Infectious Diseases 1983, 148: 131–137.

    CAS  PubMed  Google Scholar 

  3. Wara DW: Host defence againstStreptococcus pneumoniae: the role of the spleen. Reviews of Infectious Diseases 1981, 3: 299–309.

    CAS  PubMed  Google Scholar 

  4. Malagoni MA, Dillon LD, Klamer TW, Condon RE: Factors influencing the risk of early and late serious infection in adults after splenectomy for trauma. Surgery 1989, 96: 775–783.

    Google Scholar 

  5. Reinert RR, Bussing A, Kierdorf H, Kuhnemund O, Kaufhold A: Recurrent systemic pneumococcal infection in an immunocompromized patient. European Journal of Clinical Microbiology & Infectious Diseases 1994, 13: 304–307.

    Article  CAS  Google Scholar 

  6. Robbins JB, Austrian R, Lee C-J, Rastogi SC, Schiffman G, Henrichsen J, Makela PH, Broome CV, Facklam RR, Tiesjema RH, Parke Jr. JC: Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groups. Journal of Infectious Diseases 1983, 148: 1136–1159.

    CAS  PubMed  Google Scholar 

  7. Baker CN, Stocker SA: Comparison of the E-test to agar dilution, broth microdilution, and agar diffusion susceptibility testing techniques. Journal of Clinical Microbiology 1991, 29: 533–538.

    CAS  PubMed  Google Scholar 

  8. Gransden WR, Eykyn SJ, Phillips I: Pneumococcal bacteremia: 325 episodes diagnosed at St. Thomas's Hospital. British Medical Journal 1985, 290: 505–508.

    CAS  PubMed  Google Scholar 

  9. Gray BM, Dillon HC: Clinical and epidemiologic studies of pneumococcal infection in children. Pediatric Infectious Diseases 1986, 5: 201–207.

    CAS  Google Scholar 

  10. Davidson M, Parkinson AJ, Bulkow LR, Fitzgerald MA, Peters HV, Parks DJ: The epidemiology of invasive pneumococcal disease in Alaska, 1986–1990 — Ethnic differences and opportunities for prevention. Journal of Infectious Diseases 1994, 170: 368–376.

    CAS  PubMed  Google Scholar 

  11. Smart LE, Dougall AJ, Girdwood RWA: New 23-valent pneumococcal vaccine in relation to pneumococcal serotypes in systemic and non-systemic of Infection 1987, 14: 205–209.

  12. Vinter-Nielsen S, Henrichsen J: Capsular types and susceptibility to penicillin of pneumococci isolated from cerebrospinal fluid or blood in Denmark, 1983–1988. Scandinavian Journal of Infectious Diseases 1993, 25: 165–170.

    Google Scholar 

  13. Parkinson AJ, Davidson M, Fitzgerald MA, Bulkow LR, Parks DJ: Serotype distribution and antimicrobial resistance patterns of invasive isolates ofStreptococcus pneumoniae: Alaska 1986–1990. Journal of Infectious Diseases 1994, 170: 461–464.

    CAS  PubMed  Google Scholar 

  14. Austrian R: Pneumococcal polysaccharide vaccines. Review of Infectious Diseases 1989, 11: 598–602.

    Google Scholar 

  15. Paton JC, Togood IR, Cockington RA, Hansman D: Antibody response to pneumococcal vaccine in children aged 5–15 years. American Journal of Diseases in Children 1986, 140: 135–138.

    CAS  Google Scholar 

  16. Steinhoff MC: Developing and deploying pneumococcal and haemophilus vaccines. Lancet 1993, 342: 630–631.

    Article  CAS  PubMed  Google Scholar 

  17. Allen KD: Penicillin-resistant pneumococci. Journal of Hospital Infections 1991, 17: 3–13.

    CAS  Google Scholar 

  18. Handwerger S, Tomasz A: Alternations in penicillinbinding proteins of clinical and laboratory isolates of pathogenicStreptococcus pneumoniae with low levels of penicillin resistance. Journal of Infectious Diseases 1986, 153: 83–89.

    CAS  PubMed  Google Scholar 

  19. Kristinsson KG, Hjalmarsdottir MÅ, Steingrimsson O: Increasing penicillin resistance in pneumococci in Iceland. Lancet 1992, 339: 1606–1607.

    Article  CAS  PubMed  Google Scholar 

  20. Ekdahl K, Kamme C: Increasing resistance to penicillin inStreptococcus pneumoniae in Southern Sweden. Scandinavian Journal of Infectious Diseases 1994, 26: 301–305.

    CAS  PubMed  Google Scholar 

  21. Halloway Y, Schiphuis J, Kooistra-Smid M, Snijder JAM, Appelbaum PC, Spangler SK: Multiply resistant pneumococci in the Netherlands. European Journal of Clinical Microbiology & Infectious Diseases 1994, 13: 322–323.

    Google Scholar 

  22. Klugman KP, Coffey TJ, Smith A, Wasas A, Meyers M, Spratt BG: Cluster of erythromycin-resistant variant of the Spanish multiply resistant 23F clone ofStreptococcus pneumoniae in South Africa. European Journal of Clinical Microbiology & Infectious Diseases 1994, 13: 171–174.

    CAS  Google Scholar 

  23. Sessegolo JF, Levin AS, Levy CE, Asensi M, Facklam RR, Teixeria LM: Distribution of serotypes and antimicrobial resistance ofStreptococcus pneumoniae strains isolated in Brazil from 1988 to 1992. Journal of Clinical Microbiology 1994, 32: 906–911.

    CAS  PubMed  Google Scholar 

  24. Jones RN, Erwin ME, Bale M: New insights into the activity of third-generation cephalosporins against pneumonia-causing bacteria. Diagnostic Microbiology and Infectious Diseases 1992, 15: 73–80.

    CAS  Google Scholar 

  25. Bradley JS, Connor JD: Ceftriaxone failure in meningitis caused byStreptococcus pneumoniae with reduced susceptibility to beta-lactam antibiotics. Pediatric Infectious Diseases 1991, 10: 871–873.

    CAS  Google Scholar 

  26. Kalager T, Andersen BM, Bergan T, Brubakk O, Bruun JN, Døskeland B, Hellum KB, Hopen G, van der Lippe E, Rahm V, Ritland S, Schreiner A: Ciprofloxacin versus tobramycin/cefuroxime combination in the treatment of serious systemic infections. A prospective, randomized and controlled study of efficacy and safety. Scandinavian Journal of Infectious Diseases 1992, 24: 637–646.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medical Microbiology, University Hospital, Tromsø, 9038, Tromsø, Norway

    T. Magnus & B. M. Andersen

Authors
  1. T. Magnus
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B. M. Andersen
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Magnus, T., Andersen, B.M. Serotypes and resistance patterns ofStreptococcus pneumoniae causing systemic disease in northern norway. Eur. J. Clin. Microbiol. Infect. Dis. 14, 229–234 (1995). https://doi.org/10.1007/BF02310362

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02310362

Keywords

Search

Navigation